Updated:
Shin Kong Venture Capital
Shin Kong Venture Capital is the venture arm of Taiwan's Shin Kong Group, investing in US and Asian technology and healthcare companies.
Shin Kong Venture Capital
Shin Kong Venture Capital was established as the venture arm of Shin Kong Group, a Taiwanese conglomerate founded in the 1960s with roots in life insurance and financial services. The group's core entities include Shin Kong Life Insurance, Shin Kong Financial Holdings, and Shin Kong Bank. The venture unit operates with a mandate to deploy corporate capital into high-growth private companies, primarily in the US and Asia. Shin Kong Venture Capital targets early- and growth-stage companies in technology and healthcare. Its portfolio spans enterprise software, AI/ML, digital health, and healthcare services. The firm typically invests as a limited partner in venture funds and through direct co-investments alongside US-based venture firms. Confirmed investments include participation in rounds for companies such as the AI-driven drug discovery firm Insilico Medicine and the enterprise software platform FlexSim (per public record). The geographic focus is predominantly the United States, with secondary attention to Taiwan and broader Asia. The firm does not publicly disclose AUM, team size, or investment pace. It is one of several investment entities under the Shin Kong Group umbrella, which also manages public equities, real estate, and insurance reserves through separate subsidiaries. The venture office in Philadelphia and Palo Alto suggests a priority on US deal flow, particularly on the East and West Coasts. Shin Kong Venture Capital's structural differentiator is its position as a corporate venture capital arm of a major Asian financial conglomerate. This allows it to offer portfolio companies a combination of capital and potential strategic relationships across Shin Kong's insurance, banking, and healthcare businesses in Taiwan. Its small team and direct investment focus distinguish it from larger multi-family offices or institutional allocators that primarily commit to funds.
General information
Firm type
Asset Manager
Year founded
—
AUM
Undisclosed
Location
Region
Asia
Country
Taiwan
City
Taipei
Corporate office
Taipei, Taiwan
Additional offices
Philadelphia · Palo Alto
Sector focus
Frequently asked questions
Who makes investment decisions at Shin Kong Venture Capital?
Shin Kong Venture Capital does not publicly disclose its investment committee or principals. The firm operates as a corporate venture capital arm of Shin Kong Group, so decisions likely involve senior management from the group's insurance and financial holdings divisions (per the firm's corporate structure).
Does Shin Kong Venture Capital invest as a limited partner in funds or only via direct deals?
The firm participates in both fund commitments and direct co-investments. Public records show the firm has made direct investments in companies like Insilico Medicine (per public record), suggesting a dual strategy of fund investments and direct equity stakes alongside US venture partners.
What investment stages does Shin Kong Venture Capital target?
Shin Kong Venture Capital focuses on early- to growth-stage companies. Its portfolio includes both venture-stage and later-stage private companies in technology and healthcare (per public record).
Which sectors does Shin Kong Venture Capital explicitly avoid?
The firm does not publicly disclose any sector restrictions. Based on its known portfolio, it appears to avoid energy, real estate, and consumer-facing businesses, focusing instead on enterprise software, AI/ML, and healthcare.
How is Shin Kong Venture Capital related to Shin Kong Group?
Shin Kong Venture Capital is the corporate venture capital arm of Shin Kong Group, a Taiwanese conglomerate whose primary businesses include life insurance (Shin Kong Life), banking (Shin Kong Bank), and financial holdings. The venture unit invests capital from the group's balance sheet, not external LP commitments (per public record and corporate structure).
Where does the underlying wealth for Shin Kong Venture Capital come from?
The capital originates from Shin Kong Group's insurance premiums, banking deposits, and retained earnings from its financial services operations. The group is publicly listed on the Taiwan Stock Exchange and is controlled by the Wu family (per public record).
Does Shin Kong Venture Capital maintain any philanthropic or non-investment activities?
Shin Kong Group operates a separate corporate social responsibility program, the Shin Kong Life Cultural & Educational Foundation, which focuses on arts, education, and elderly care in Taiwan. The venture capital arm does not directly manage these activities (per the group's official communications).
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: